Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.

@article{Bonnema2012RadioiodineTI,
  title={Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.},
  author={Steen Joop Bonnema and Laszlo Heged{\"u}s},
  journal={Endocrine reviews},
  year={2012},
  volume={33 6},
  pages={920-80}
}
Radioiodine ((131)I) therapy of benign thyroid diseases was introduced 70 yr ago, and the patients treated since then are probably numbered in the millions. Fifty to 90% of hyperthyroid patients are cured within 1 yr after (131)I therapy. With longer follow-up, permanent hypothyroidism seems inevitable in Graves' disease, whereas this risk is much lower when treating toxic nodular goiter. The side effect causing most concern is the potential induction of ophthalmopathy in predisposed… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

Similar Papers

Loading similar papers…